University of Patras
Διερεύνηση του μηχανισμού της αιμοποίησης στα μυελοδυσπλαστικά σύνδρομα με μακράς διάρκειας καλλιέργειες μυελού των οστών: επίδραση αυξητικών παραγόντων και κυτταροκινών
Abstract
dc:descriptionMyelodysplastic syndromes comprise a heterogeneous group of hematopoietic stem-cell disorders, with dismal prognosis and difficulty in their therapeutic approach. Their classification according to FAB co-operative study group initially, and more recently according to WHO, as well as the application of several prognostic scoring systems, aim to predict the time to evolution to acute leukemia and the overall survival. The main therarapeutic approach is based on the supportive care and the use of hematopoietic growth factors, whereas many other factors have been used, in an effort to differentiate the dysplastic clone. The revealing of the underlying pathogenetic mechanisms, which are implicated in the impaired hematopoiesis of these syndromes, is crucial for the development a more comprehensive and effective treatment approaches. The study of hematopoiesis in vitro can be accomplished by several methods, but mainly by hematopoietic progenitor-cell cultures performed in various conditioned mediums, by using cells derived from the peripheral blood or bone marrow. Short term cultures are useful for the study and development of the commited progenitors, while long term cultures provide the possibility of development to the more primitive pluripotent stem cells, on a cell environment, consisting of accessory cells, implicated in the creation of the marrow microenvironment in vivo. Long term cultures comprise the more relevant in vitro model of hematopoiesis, and they greatly contribute to the understanding of cellular interactions between hematopoietic and stromal cells. The aim of this thesis was the study of hematopoiesis of MDS, by using long term cultures of hemopoietic cells and the investigation of the influence of various exogenous modulating factors-drugs in vitro, in an effort to obtain results, which could direct their use in vivo. Short term cultures in methylcellulose revealed the disability of the progenitor cells of patients to form colonies of equal size and number to those of normal controls, and this disability was more prominent in high risk patients, such as RAEB and RAEB-t. The addition of erythropoietin and of a mixture of growth factors in the conditioned medium had a positive influence in the majority of cases, which was more prominent than the corresponding of the normal controls. Attempting to use the in vitro data, as a predictive model of the in vivo response to combination therapy with erythropoietin plus G-CSF, hematopoietic cells of patients with RARS were cultured and the impact of the growth factors-enriched medium on the formation of colonies was compared with the in vivo response. No correlation between in vitro and in vivo results was found, and this was attributed to the different composition of the combination of hematopoietic growth factors added to the cultures, which is not yet available for in vivo use. The aim of this thesis was the study of in vitro hematopoiesis of MDS patients using mainly long term cultures. First, we compared the results obtained from patients with MDS, with those obtained from normal controls, and then the results were compared between the different subgroups of the FAB classification. For this comparison 4 growth parameters of the culture were used: the extent of the area of the stroma-layer formed, the longevity of the culture, the weekly cell production in the supernatant medium and the total cell yield of each culture. In all cases the development of cultures derived from patients was inferior to those of controls, as it could be estimated by the four above-mentioned parameters. The model was much more worse in patients suffering from RAEB and RAEB-t, in comparison to the model obtained from patients belonging to other FAB subgroups. The addition of modulating factors to the culture medium was aimed to improve the above parameters and their choice was based on data emerging from the literature, where a favorable influence on the patients’ hematopoiesis, as well as a differentiation effect on their progenitors in vitro had been confirmed. IFN-α, used in two different concentrations, did not improve the results in comparison to the controls, while -especially in the higher concentration- it had a clear cell-toxic effect. The same results were obtained with the addition of arabinosylcytosine, in two different concentrations, as well as with the combination of IFN-α and aracytine. The addition of vitamin D3 had no significant impact, since it did not improve any of the culture’s parameter. The addition of IL-3 had a clearly favorable effect in the majority of cases, increasing, mainly the weekly and the total cell yield of the culture’s supernatant, and to a lesser degree improving the other parameters of the culture. However, in a subgroup of high-risk patients, very high cell yield was associated to patient’s evolution to a more aggressive syndrome or acute myelogenous leukemia, implying that IL-3 might probably enhance clonal expansion of the blast cell population. Interleukin-6 had similarly a favourable effect, but this was particularly prominent in the stroma-cell formation and to a lesser degree in the other culture parameters. The combination of IL-3 plus IL-6 was proved as the most important favourable modulator of the MDS cultures. It improved all culture parameters in the vast majority of patients, and produced statistically significant differences in comparison to the control cultures. Therefore, a clear synergy between the two interleukins was observed, particularly in the extent and the overall quality of the stroma formation, which had a positive impact on all the remaining culture parameters used for the evaluation of the long term cultures. By using the combination of IL-3 plus IL-6 the development of the stroma-cell layer approached and in some cases reached the level of development of the normal controls. The improvement of the total cell yield was not significantly different of that observed by the addition of IL-3 alone, a finding implying that this cytokine is the main regulator of cell proliferation. According to the developmental model obtained by the long-term culture and the response to the modulators added, two different patterns of in vitro growth could be distinguished: The dysplastic model, which is characterized by some degree of stroma formation, however rapidly degenerated during the 5th to 6th week, and incapable to support a strong culture system, and a corresponding low cell-yield in the supernatant. This model in some cases can approach the normal growth pattern, from which it generally differs rather quantitatively. The second is the leukemic model, which is characterized by a complete inability for stroma formation, short overall longevity of the culture, and high cell yield during the first two weeks, attributed to the initially inoculated committed progenitor cells in the culture. The MDS patients’ stroma-cell layer has a distinct cytokine profile, characterized by the absence of GM-CSF expression and a low expression of SCF, TGF-β and TNF-α. In conclusion, long term cultures of hematopoietic cells of patients with MDS represent a useful prognostic tool and can distinguish patients who will more rapidly evolve to leukemia from those who will have a more prolonged and stable clinical course. The use of a combination of cytokines and other factors might have a favourable effect on the impaired in vitro hematopoiesis of the progenitor cells of patients with MDS.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kourakli-Symeonidou, Alexandra
- Κουράκλη-Συμεωνίδου, Αλεξάνδρα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26511